User login
Key clinical point: Providers should consider screening for hazardous cannabis use, especially if patients report depression, anxiety, or difficulty sleeping.
Major finding: Patients with MS who are depressed, anxious, or have poor sleep may be more likely to misuse or abuse cannabis.
Study details: 100 patients with a confirmed MS diagnosis who were receiving outpatient care in a university-affiliated MS center.
Disclosures: No study funding was reported and the authors report no relevant disclosures.
Citation: REPORTING FROM CMSC 2019
Key clinical point: Providers should consider screening for hazardous cannabis use, especially if patients report depression, anxiety, or difficulty sleeping.
Major finding: Patients with MS who are depressed, anxious, or have poor sleep may be more likely to misuse or abuse cannabis.
Study details: 100 patients with a confirmed MS diagnosis who were receiving outpatient care in a university-affiliated MS center.
Disclosures: No study funding was reported and the authors report no relevant disclosures.
Citation: REPORTING FROM CMSC 2019
Key clinical point: Providers should consider screening for hazardous cannabis use, especially if patients report depression, anxiety, or difficulty sleeping.
Major finding: Patients with MS who are depressed, anxious, or have poor sleep may be more likely to misuse or abuse cannabis.
Study details: 100 patients with a confirmed MS diagnosis who were receiving outpatient care in a university-affiliated MS center.
Disclosures: No study funding was reported and the authors report no relevant disclosures.
Citation: REPORTING FROM CMSC 2019